20
Participants
Start Date
November 30, 2007
Primary Completion Date
November 30, 2008
Study Completion Date
November 30, 2008
Imatinib Mesylate
Imatinib Mesylate: 400mg po BID every day. Imatinib Mesylate will be administered Day 2 to Day 15
CLAG
"Cladribine: 5mg/m2 administered through a 2 hour intravenous infusion daily for 5 consecutive days starting on Day 2~Cytarabine: 2gm/m2 administered through a 4 hour intravenous infusion starting 2 hours after the ignition of Cladribine for 5 days starting on Day 2~G-CSF: 300mcg sc for 6 days starting at 24 hours (Day 1) before the first dose of Cladribine; administration starting on Day 1 for 6 days"
University of Cincinnati, Cincinnati
Collaborators (1)
Novartis
INDUSTRY
University of Cincinnati
OTHER